News

Updates

AACR Annual Meeting 2017
April 1-5, 2017 • Washington, D.C

ASCO Annual Meeting 2017
June 2-6, 2017 • Chicago, Illinois

IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay
March 30, 2017

IncellDx Launches OncoTect iO™ Quantitative, Single Cell PD-L1 Assay
March 07, 2017

IncellDx Partners with Celsee Diagnostics Announces Immuno-Oncology Research Agreement
February 14, 2017

IncellDx presents poster at IASLC 17th World Conference on Lung Cancer
December 5, 2016

IncellDx and Beckman Coulter Sign Distribution Partnership in China, Hong Kong and Taiwan to Benefit Human Papilloma Virus (HPV) Research
November 12, 2015

IncellDx presents poster at GLIFCA 2015 in Buffalo, NY.
September 27, 2015

IncellDx presents poster at IPV 2015 in Lisbon
September 21, 2015

IncellDx Stikes a partnership with Claremont-BioSolutions
April 14, 2015

MD Anderson and PPRI uses IncellDx’s OncoBreast3Dx® Technology.
January 27, 2015

Journal of Clinical Microbiology publishes New HIV article by IncellDx.
October 29, 2014

IncellDx Signs Agreement with Bristol-Myers Squibb Related to the Development of an Assay for a Companion Diagnostic Test
October 29, 2013

IncellDx Signs Deal with CureHealth Diagnostics to Offer New HPV Technology in India
June 21, 2013

IncellDx Signs Deal with Kindstar Global to Offer Novel HPV Technology in China
June 11, 2013

IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast Cancer Technology
January 8, 2013

IncellDx Receives North American Product Leadership Award in the Molecular Diagnostics Market from Frost & Sullivan
July 19, 2012

BRLI Announces IncellDx Investment and Launch of GenCerv Test Through Its GenPath Women’s Health Laboratory
April 30, 2012

IncellDx Announces the Expansion of HPV OncoTect® E6, E7 mRNA by Labco Laboratories Throughout Europe
February 8, 2012

IncellDx CEO applauds new cervical cancer screening recommendations- Technology identifies cancer with more certainty than current tests
October 21, 2011

Enzo Biochem Reaches Marketing Deal for IncellDx’s HPV Test
June 10, 2011

IncellDx Unveils Revolutionary New Technology In The Fight Against Cancer
May 10, 2011

IncellDx Announces New Director of Research and Development
March 17, 2011

IncellDx, Inc. Receives ISO 13485:2003 and ISO 9001:2008 Certifications
March 3, 2011

IncellDx Biotech Company of the Year
December 2, 2010

IncellDx Announces Successful Presentation of its Personalized HIV Monitoring Assays at the 5th Santorini Conference in Greece
October 5, 2010

IncellDx Announces Successful Presentation of Complete Solution for Cervical Cancer Screening at International HPV Conference in Montreal
July 9, 2010

IncellDx Secures $3 Million in Series A Financing
June 8, 2010

IncellDx Announces Expansion Of Senior Management Team
May 19, 2010

IncellDx Announces a Supply Agreement with Accuri to Offer Complete Solution for Cervical Cancer Screening
May 6, 2010

Silicon Venture Personalized Medicine Presentation
January 19, 2010